Chapter 142 The restless capitalists
After all, the prospects for gene editing technology are so broad. Not to mention other things, the medical industry alone has a market size of over one trillion dollars.

However, the key core technology patents at this time are controlled by Xingtu Gene Company. How can global capital not be extremely jealous?
Of course, although global capital is jealous of Xingtu Gene Company, Xingtu Gene Company is ultimately a Daxia enterprise, and the country of Daxia has always been very special.

Therefore, although global capital is eager to swallow up Xingtu Gene Company through overt or covert means, it can only follow the rules under the restraint of Daxia.

This is also an invisible benefit of having the support of the Great Xia Kingdom.

If Xingtu Gene Company was an enterprise in a small Southeast Asian country, or even in Han or Yamato, it would definitely be devoured by global capital.

After all, overseas is a world where capital and strength are king. Even with the advent of the Internet age, global capitalists have become more restrained in their actions.

But which capital’s rise has not been stained with the blood of innocent people?
Therefore, if Xingtu Gene Company is a company from overseas countries, it will not be able to support itself without the support of official strength, underground strength and overt strength.

It would definitely not be able to sustain it, and it would not have developed to the current level.

Of course, faced with trillions of dollars in profits, no matter how strong the company's overseas strength is, it will be in vain. Faced with global capital, it will eventually have to cut meat to feed the eagles.

However, Xingtu Gene Company is not a company from overseas countries, but a company from Daxia Country.

If they want to deal with Lin Feng and Xingtu Gene Company, they have to go through Daxia Kingdom after all, so they can't do anything to Xingtu Gene Company.

Therefore, Xingtu Gene Company has escaped a fatal disaster, which can be regarded as an unexpected surprise.

Of course, although overseas capital cannot seize the market by force, they will not give up when faced with a market size of over one trillion US dollars.

So as global capital was activated by the craze for gene editing technology, a huge investment boom swept across the world.

This investment boom is only a few points lower than the Internet investment boom of that year, and it can be said to be quite fierce.

Among them, all companies related to gene editing technology have received invitations to invest and raise funds.

Even medical and pharmaceutical companies that have nothing to do with gene editing technology have benefited from this turbulent capital investment boom.

Well-known pharmaceutical giants such as Johnson & Johnson, Pfizer, Novartis, Sanofi, GlaxoSmithKline...

The market value of all the old medical companies soared by about 15% to 30% in just a few days, which was a real surge.

Obviously, global investors believe that with the decades and centuries of foundation of these old companies, they will definitely be one of the ultimate winners in this new wave of gene editing technology.

Therefore, those smart people also entered the market early and rushed to buy shares of those old pharmaceutical companies in order to get a piece of the pie.

Of course, compared with the old pharmaceutical companies, the Broad Institute and the Max Planck Institute, which hold core technology patents, are the focus of global capital circles.

After all, core technology patents are the backbone of an enterprise. Otherwise, no matter how big your factory is or how many workers you have, it is ultimately just a OEM factory.

As a result, the doors of the Max Planck Institute and the Broad Institute were constantly visited by people, and countless companies were contacting them.

Among them, Church, the director of the Broad Institute, is also very good at manipulating current affairs, so Church and Zhang Feng had made preparations in advance.

Broad Institute Director Church directly and publicly announced that Zhang Feng of the Broad Institute has made a major breakthrough in gene editing technology.

In the video footage released by the Broad Institute, a series of detailed data parameters were used to prove that the Broad Institute has successfully eliminated the SIV simian immunodeficiency virus!
In other words, the research and development progress of the Broad Institute seems to have reached the level of the EBT-001 gene medical drug originally developed by Starway Genetics.

Under such circumstances, it seems that the Broad Institute is not far from the EBT-002 gene therapy drug.

So as people thought this, companies that wanted to invest in the Broad Institute became more enthusiastic and excited.

Of course, the work of the director of the Broad Institute, Church, is not limited to this. After announcing the successful elimination of the SIV monkey immunodeficiency virus, Church, the director of the Broad Institute, publicly declared that after Zhang Feng successfully eliminated the SIV monkey immunodeficiency virus, he was fully confident about how to solve the human AIDS virus.

The director of the Broad Institute, Church, proudly declared that within a month, they would be able to control the AIDS virus, and then take the opportunity to apply for human trials!
In this regard, the words of Church, director of the Broad Institute, were like adding a barrel of gasoline to the burning fire.

So under such circumstances, the Broad Institute successfully became the center of public opinion and the center of the global capital investment boom. At this time, the Broad Institute could naturally close its net.

In the end, it only took a week for the Broad Institute to publicly announce that it had received a huge investment of $350 billion!

Of course, no matter how much investment funds are obtained, it is ultimately just a string of numbers. What netizens care more about are the investment companies behind them.

Among these invested companies, there are global pharmaceutical giants and even well-known investment companies on Wall Street.
Among them, pharmaceutical giants include Johnson & Johnson, Pfizer, Novartis, Sanofi, GlaxoSmithKline...

As for the well-known investment companies on Wall Street, there are many of them, dozens of them. It can be said that every well-known investment company has invested in the Broad Institute.

Faced with this situation, people knew that the Broad Institute was about to take the lead.

Because the investments from pharmaceutical giants and Wall Street Capital bring not only money, but also various other intangible benefits.

No matter what the Broad Institute does next, everything will go smoothly and everything will go well.

Of course, let’s not talk about those empty things, but the real benefits.

Relying on the alliance with those global pharmaceutical giants, the next are the gene editing companies controlled by various pharmaceutical giants and Wall Street Capital.

It is estimated that they will also send their own scientific researchers to join the Broad Institute in an attempt to get a piece of the pie and have more say.

What does the Broad Institute think about this matter?
Naturally, they would not reject others' interference. After all, they are just a research and development institution and do not have their own factory.

So when others took the initiative to support scientific researchers, Church was naturally ecstatic and accepted all of them.

With the support of this group of qualified and talented scientific researchers, the Broad Institute is more confident in quickly putting the "viral transformation method" into practical use.

Therefore, through this series of major actions prepared in advance, the Broad Institute became the leader of this wave of capital investment and one of the biggest winners.

This will also bring certain potential risks to Xingtu Gene Company. After all, there is no room for two tigers in one mountain.

At this time, the Broad Institute itself had Zhang Feng, a research and development genius in the field of gene editing. In addition, Church was ruthless and prepared to use the lives of people in backward areas to quickly advance scientific research results.

Now there is a huge cash flow of 350 billion US dollars to support it, plus the support of scientific researchers provided by pharmaceutical giants and pharmaceutical companies controlled by Wall Street Capital...

With the joint efforts of multiple parties, they may be able to catch up with the current R&D progress of Xingtu Gene Company within one or two years.

Make the 'virus transformation technology route' as practical as the current 'RNP complex technology route'.

If they really do this, even if there are some hidden dangers, as long as they can achieve the basic goal of editing the genes of cells throughout the body.

Then the value of the technical patents held by Xingtu Gene Company will inevitably plummet.

Finally, since the Broad Institute is backed by a coalition of pharmaceutical giants, it will be extremely difficult for Starway Genetics to compete with these giants for the medical market share.

After all, when ordinary people need treatment for illnesses, they will definitely give priority to those famous century-old pharmaceutical giants.

After all, the reputation and credibility of Xingtu Gene Company, which was established only a few years ago, is too low, and it is not people's first choice.

(End of this chapter)